EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease

Anamaria Jurcau, Felicia Liana Andronie-Cioara, Delia Carmen Nistor-Cseppento iD, Nicoleta Pascalau, Marius Rus, Elisabeta Vasca, Maria Carolina Jurcau

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241914582 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Anamaria Jurcau und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psycho-Neuroscience and Rehabilitation, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania. Hauptthemen laut MEDLINE: Parkinson Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 351 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease is a neurodegenerative disease exhibiting the fastest growth in incidence in recent years. As with most neurodegenerative diseases, the pathophysiology is incompletely elucidated, but compelling evidence implicates inflammation, both in the central nervous system and in the periphery, in the initiation and progression of the disease, although it is not yet clear what triggers this inflammatory response and where it begins. Gut dysbiosis seems to be a likely candidate for the initiation of the systemic inflammation. The therapies in current use provide only symptomatic relief, but do not interfere with the disease progression. Nonetheless, animal models have shown promising results with therapies that target various vicious neuroinflammatory cascades. Translating these therapeutic strategies into clinical trials is still in its infancy, and a series of issues, such as the exact timing, identifying biomarkers able to identify Parkinson’s disease in early and pre-symptomatic stages, or the proper indications of genetic testing in the population at large, will need to be settled in future guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseNeurodegenerative DiseasesAnimalsNeuroinflammatory DiseasesInflammationBiomarkersMicroglia

Stichwörter der Autor:innen

M1 phenotypeM2 phenotypeParkinson’s diseaseastrogliagut dysbiosismicroglianeuroinflammationsignaling pathwaystherapyα-synuclein

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Psycho-Neuroscience and Rehabilitation, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
  • Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.
  • Department of Oral Rehabilitation, Faculty of Medicine "Vasile Goldis" Arad, 310025 Arad, Romania.
  • Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.

ORCID-Profile: Delia Carmen Nistor-Cseppento

Zitieren

APA

Jurcau, A., Andronie-Cioara, F. L., Nistor-Cseppento, D. C., Pascalau, N., Rus, M., Vasca, E., & Jurcau, M. C. (2023). The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914582

Vancouver

Jurcau A, Andronie-Cioara FL, Nistor-Cseppento DC, Pascalau N, Rus M, Vasca E, et al. The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914582

BibTeX
@article{Jurcau2023,
  author = {Jurcau, Anamaria and Andronie-Cioara, Felicia Liana and Nistor-Cseppento, Delia Carmen and Pascalau, Nicoleta and Rus, Marius and Vasca, Elisabeta and Jurcau, Maria Carolina},
  title = {The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241914582}
}
Kostenlos starten →